hyperthyroidism glp 1 GLP-1 Medications & Thyroid Function The Truth About GLP-1s, Thyroid

The clinical trial starting dose (1 mg/week) is already close to the community protocol (1.5 mg/week split 3x)

If your current prescriber does not offer this, asking for a referral to a registered dietitian who specializes in obesity medicine is a reasonable step

Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, et al

As the dose climbs, the balance changes

"But these websites are also not carefully screening their patients and evaluating whether the person needs the medication

This is a pre-filled injection format of LY3437943, a triple agonist binding GIP, GLP-1 and glucagon receptors currently in Phase 3 trials expected to conclude in May 2026 [6][8]